-

Agilent Announces New Mass Spectrometry Products at ASMS 2020 Reboot

Mass spec systems address needs of the pharma, biopharma, food, environmental, and life science markets

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced two new mass spectrometry (MS) products: the Agilent 6470B Triple Quadrupole LC/MS (6470 LC/TQ) system, and the Agilent RapidFire 400 system. Both deliver even faster detection of target compounds providing customers increased sample throughput and reduced time to generate results. The instruments are being introduced at ASMS 2020 Reboot, the interactive, online version of the annual conference of the American Society for Mass Spectrometry, being held June 1-12, 2020.

“Agilent continues to strive to meet the evolving needs of our mass spec customers, and address the challenges they face daily,” said Monty Benefiel, vice president, and general manager of Agilent's Mass Spectrometry Division. “These new products offer customers workflow solutions that maximize sample throughput and stability, as well as greater reliability than ever before.”

The 6470B system includes enhancements that boost system uptime and improve overall system performance for low-level detection in routine, high-throughput environments. Customers running a single chromatographic method for applications such as multi-residue screening will see greater data fidelity, reproducibility, and sensitivity. The system integrates seamlessly into existing analytical labs and customer workflows—and it offers quicker routine maintenance through the addition of VacShield technology, designed to easily remove ion injectors without venting.

The high-throughput RapidFire 400 integrated autosampler provides fast results with cycle times as short as 2 sec/sample and adds optional sample cooling for greater sample stability. The system includes barcode reading capabilities for sample tracking, now supports 1,536 well plates, and allows unattended operation for the analysis of more than 98,000 samples. It is further designed to integrate with the Ultivo LC/TQ system, further reducing lab space requirements.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenue of $5.16 billion in fiscal 2019 and employs 16,300 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn, Twitter, and Facebook.

Contacts

Naomi Goumillout
Agilent Technologies
+1.781.266.2819
naomi.goumillout@agilent.com

Agilent Technologies Inc.

NYSE:A
Details
Headquarters: Santa Clara, California, USA
CEO: Padraig McDonnell
Employees: 18000
Organization: PUB

Release Versions

Contacts

Naomi Goumillout
Agilent Technologies
+1.781.266.2819
naomi.goumillout@agilent.com

More News From Agilent Technologies Inc.

Agilent to Announce Second-Quarter Fiscal Year 2026 Financial Results on May 27

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the second quarter of fiscal year 2026 after the stock market closes on Wednesday, May 27. The company will host a conference call to discuss the results at 1:30 p.m. PDT the same day. To join the listen-only conference call webcast, click the link on the Events section of Agilent’s Investor Relations website. A recording of the call will also be available on the website for 90 days. Abo...

Agilent Showcases Cancer Research Solutions at AACR 2026

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will present new technologies, scientific collaborations, and integrated workflows supporting cancer research and diagnostics at the American Association for Cancer Research (AACR) Annual Meeting on April 17–22, 2026, in San Diego, California. At the meeting, Agilent will highlight advances designed to connect discovery research, translational science, and companion diagnostics development, reflecting the growing demand f...

Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation portfolio combining multimode microplate reading and high-content cell imaging in a single platform. Building on a decade of Cytation innovation and shaped by continuous customer feedback, the BioTek Cytation 9 helps laboratories move from samples to insights faster, supporting workflows from basic resea...
Back to Newsroom